http://rdf.ncbi.nlm.nih.gov/pubchem/reference/8749297

Outgoing Links

Predicate Object
contentType Journal Article|Research Support, Non-U.S. Gov't
endingPage 38704
issn 1949-2553
issueIdentifier 36
pageRange 38695-38704
publicationName Oncotarget
startingPage 38695
bibliographicCitation Mlcochova J, Faltejskova-Vychytilova P, Ferracin M, Zagatti B, Radova L, Svoboda M, Nemecek R, John S, Kiss I, Vyzula R, Negrini M, Slaby O. MicroRNA expression profiling identifies miR-31-5p/3p as associated with time to progression in wild-type RAS metastatic colorectal cancer treated with cetuximab. Oncotarget. 2015 Nov 17;6(36):38695–704. PMID: 26497852; PMCID: PMC4770730.
creator http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_80bc27174ae3ee5de7c2a1cf9a2b01b8
http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-0007-1920
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_ef012e295fd8bfbc2c06116e9856de31
http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0003-0063-2078
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_ab61131179d8eabf471d474dce7e9566
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_e7bc9823172feccec585aefc27cdc82d
http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0001-7693-0659
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_35d9fa71ff49c712f2d66bbbcc617438
http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0001-8103-148X
http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-1595-6887
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_1345755bb34c14a5f6a7d10f5cddaf3e
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_dd37612f0d8ff4532ed9012a7f41befc
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_a5dcf394386eaa01bf9fdfd1b65347ca
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_3e42ee04b04aa68901cd76575cacdb61
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_803c81ee93c086b5971dccf7902a76e7
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_d46d159d62b325c502a02a751b62b098
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_92accff65b8c816785fbe56e2d40e381
date 2015-10-20^^<http://www.w3.org/2001/XMLSchema#date>
identifier https://pubmed.ncbi.nlm.nih.gov/26497852
https://doi.org/10.18632/oncotarget.5735
https://pubmed.ncbi.nlm.nih.gov/PMC4770730
isPartOf http://rdf.ncbi.nlm.nih.gov/pubchem/journal/37803
https://portal.issn.org/resource/ISSN/1949-2553
language English
source https://www.crossref.org/
https://pubmed.ncbi.nlm.nih.gov/
title MicroRNA expression profiling identifies miR-31-5p/3p as associated with time to progression in wild-type RAS metastatic colorectal cancer treated with cetuximab
discusses http://id.nlm.nih.gov/mesh/M0001483
http://id.nlm.nih.gov/mesh/M0407989
http://id.nlm.nih.gov/mesh/M0001357
http://id.nlm.nih.gov/mesh/M0027924
http://id.nlm.nih.gov/mesh/M0528849
http://id.nlm.nih.gov/mesh/M0593322
http://id.nlm.nih.gov/mesh/M0422675
http://id.nlm.nih.gov/mesh/M0484911
http://id.nlm.nih.gov/mesh/M0500817
hasPrimarySubjectTerm http://id.nlm.nih.gov/mesh/D000970Q000627
http://id.nlm.nih.gov/mesh/D015179Q000188
http://id.nlm.nih.gov/mesh/D015179Q000235
http://id.nlm.nih.gov/mesh/D000911Q000627
http://id.nlm.nih.gov/mesh/D000068818Q000627
http://id.nlm.nih.gov/mesh/D035683Q000096
hasSubjectTerm http://id.nlm.nih.gov/mesh/D015331
http://id.nlm.nih.gov/mesh/D019073
http://id.nlm.nih.gov/mesh/D066246Q000037
http://id.nlm.nih.gov/mesh/D006801
http://id.nlm.nih.gov/mesh/D035683Q000235
http://id.nlm.nih.gov/mesh/D008297
http://id.nlm.nih.gov/mesh/D045325
http://id.nlm.nih.gov/mesh/D008875
http://id.nlm.nih.gov/mesh/D000077544
http://id.nlm.nih.gov/mesh/D000970Q000008
http://id.nlm.nih.gov/mesh/D015179Q000378
http://id.nlm.nih.gov/mesh/D015179Q000473
http://id.nlm.nih.gov/mesh/D000368
http://id.nlm.nih.gov/mesh/D000328
http://id.nlm.nih.gov/mesh/D018631Q000235
http://id.nlm.nih.gov/mesh/D005260
discussesAsDerivedByTextMining http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9672
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8607
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8603
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_fddb60309b0ee16f8cd57b4b90c99e89

Showing number of triples: 1 to 70 of 70.